Concepts (60)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Long Interspersed Nucleotide Elements | 1 | 2016 | 330 | 0.450 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2023 | 3638 | 0.350 |
Why?
|
| DNA Methylation | 4 | 2023 | 4383 | 0.330 |
Why?
|
| DNA | 1 | 2023 | 7216 | 0.320 |
Why?
|
| Pain Insensitivity, Congenital | 1 | 2022 | 8 | 0.210 |
Why?
|
| Hypohidrosis | 1 | 2022 | 29 | 0.200 |
Why?
|
| Phospholipase C gamma | 1 | 2022 | 131 | 0.200 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2022 | 223 | 0.190 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 8592 | 0.190 |
Why?
|
| Long-Term Potentiation | 1 | 2023 | 293 | 0.190 |
Why?
|
| Receptor, trkA | 1 | 2022 | 159 | 0.190 |
Why?
|
| Melanoma | 2 | 2016 | 5706 | 0.180 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2023 | 502 | 0.180 |
Why?
|
| Neural Crest | 1 | 2022 | 279 | 0.170 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2023 | 855 | 0.170 |
Why?
|
| Mutation | 3 | 2022 | 30044 | 0.140 |
Why?
|
| Epigenesis, Genetic | 2 | 2023 | 3793 | 0.130 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2016 | 75 | 0.130 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2016 | 304 | 0.100 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2016 | 1062 | 0.100 |
Why?
|
| Protein Kinases | 1 | 2016 | 1607 | 0.080 |
Why?
|
| Cell Line | 1 | 2023 | 15599 | 0.080 |
Why?
|
| DNA Mutational Analysis | 1 | 2016 | 4108 | 0.070 |
Why?
|
| Skin Neoplasms | 2 | 2016 | 5820 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 2223 | 0.060 |
Why?
|
| Computational Biology | 1 | 2016 | 3512 | 0.060 |
Why?
|
| Channelopathies | 1 | 2022 | 30 | 0.050 |
Why?
|
| Nerve Growth Factor | 1 | 2022 | 158 | 0.050 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2022 | 286 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2016 | 5665 | 0.040 |
Why?
|
| Epigenomics | 1 | 2022 | 941 | 0.030 |
Why?
|
| Brain | 1 | 2023 | 27103 | 0.030 |
Why?
|
| Animals | 3 | 2023 | 168388 | 0.030 |
Why?
|
| Analgesics | 1 | 2022 | 1070 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2016 | 931 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2022 | 4280 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2016 | 1793 | 0.020 |
Why?
|
| Humans | 7 | 2023 | 761326 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2016 | 1218 | 0.020 |
Why?
|
| Neoplasm, Residual | 1 | 2016 | 1008 | 0.020 |
Why?
|
| Chromatin | 1 | 2022 | 2960 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2016 | 3076 | 0.020 |
Why?
|
| CpG Islands | 1 | 2015 | 1225 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2016 | 3588 | 0.020 |
Why?
|
| Pain | 1 | 2022 | 5077 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2016 | 2821 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2022 | 11531 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 5778 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2022 | 12122 | 0.010 |
Why?
|
| Genome, Human | 1 | 2015 | 4423 | 0.010 |
Why?
|
| Disease Progression | 1 | 2016 | 13500 | 0.010 |
Why?
|
| Mice | 1 | 2022 | 81474 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 58946 | 0.010 |
Why?
|
| Risk Factors | 1 | 2015 | 74152 | 0.000 |
Why?
|
| Child | 1 | 2016 | 80156 | 0.000 |
Why?
|
| Adolescent | 1 | 2016 | 88305 | 0.000 |
Why?
|
| Male | 2 | 2016 | 360621 | 0.000 |
Why?
|
| Female | 2 | 2016 | 392485 | 0.000 |
Why?
|
| Middle Aged | 1 | 2016 | 220774 | 0.000 |
Why?
|
| Adult | 1 | 2016 | 221122 | 0.000 |
Why?
|
Concepts
(60)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_